je.st
news
Researchers oppose unvalidated gene panel tests for cancer links
2015-05-27 20:40:55| Biotech - Topix.net
A group of international researchers is making the case that genetic tests that look for multiple hereditary genes suspected of being linked to breast cancer should not be offered until they are proven to be valid and useful in clinical practice. Such tests, made by several companies including Myriad Genetics Inc, Ambry Genetics, Invitae and Illumina Inc, cover up to 100 inherited cancer genes, including more than 20 for breast cancer.
Tags: links
panel
tests
cancer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|
|||